206 related articles for article (PubMed ID: 23267699)
1. Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells.
Tao YF; Lu J; Du XJ; Sun LC; Zhao X; Peng L; Cao L; Xiao PF; Pang L; Wu D; Wang N; Feng X; Li YH; Ni J; Wang J; Pan J
BMC Cancer; 2012 Dec; 12():619. PubMed ID: 23267699
[TBL] [Abstract][Full Text] [Related]
2. YM155 Down-Regulates Survivin and Induces P53 Up-Regulated Modulator of Apoptosis (PUMA)-Dependent in Oral Squamous Cell Carcinoma Cells.
Yan X; Su H
Med Sci Monit; 2017 Apr; 23():1963-1972. PubMed ID: 28435150
[TBL] [Abstract][Full Text] [Related]
3. YM155 Reverses Statin Resistance in Renal Cancer by Reducing Expression of Survivin.
Nitta T; Koike H; Miyao T; Miyazawa Y; Kato H; Furuya Y; Sekine Y; Suzuki K
Anticancer Res; 2017 Jan; 37(1):75-80. PubMed ID: 28011476
[TBL] [Abstract][Full Text] [Related]
4. Targeting of Survivin Pathways by YM155 Inhibits Cell Death and Invasion in Oral Squamous Cell Carcinoma Cells.
Zhang W; Liu Y; Li YF; Yue Y; Yang X; Peng L
Cell Physiol Biochem; 2016; 38(6):2426-37. PubMed ID: 27287458
[TBL] [Abstract][Full Text] [Related]
5. Action of YM155 on clear cell renal cell carcinoma does not depend on survivin expression levels.
Sim MY; Huynh H; Go ML; Yuen JSP
PLoS One; 2017; 12(6):e0178168. PubMed ID: 28582447
[TBL] [Abstract][Full Text] [Related]
6. Survivin selective inhibitor YM155 promotes cisplatin‑induced apoptosis in embryonal rhabdomyosarcoma.
Ueno T; Uehara S; Nakahata K; Okuyama H
Int J Oncol; 2016 May; 48(5):1847-54. PubMed ID: 26983495
[TBL] [Abstract][Full Text] [Related]
7. Targeted inhibition of survivin with YM155 promotes apoptosis of hypoxic human pulmonary arterial smooth muscle cells via the upregulation of voltage-dependent K⁺ channels.
Zhang S; Liu B; Fan Z; Wang D; Liu Y; Li J; Wang N; Liu Y; Zhang B
Mol Med Rep; 2016 Apr; 13(4):3415-22. PubMed ID: 26957114
[TBL] [Abstract][Full Text] [Related]
8. YM155, a small molecule inhibitor of survivin expression, sensitizes cancer cells to hypericin-mediated photodynamic therapy.
Gyurászová K; Mikeš J; Halaburková A; Jendželovský R; Fedoročko P
Photochem Photobiol Sci; 2016 Jun; 15(6):812-21. PubMed ID: 27241169
[TBL] [Abstract][Full Text] [Related]
9. Significance of survivin as a prognostic factor and a therapeutic target in endometrial cancer.
Chuwa AH; Sone K; Oda K; Ikeda Y; Fukuda T; Wada-Hiraike O; Inaba K; Makii C; Takeuchi M; Oki S; Miyasaka A; Kashiyama T; Arimoto T; Kuramoto H; Kawana K; Yano T; Osuga Y; Fujii T
Gynecol Oncol; 2016 Jun; 141(3):564-569. PubMed ID: 27079211
[TBL] [Abstract][Full Text] [Related]
10. YM155 induces apoptosis in p53-deficient T-acute lymphoblastic leukemia cells independent of survivin inhibition.
Sales L; de Sousa GR; Ferreira-Silva GÁ; Castro-Gamero AM; Ionta M; de Oliveira JC
Anticancer Drugs; 2017 Mar; 28(3):298-306. PubMed ID: 27930382
[TBL] [Abstract][Full Text] [Related]
11. Small Molecule Survivin Inhibitor YM155 Displays Potent Activity Against Human Osteosarcoma Cells.
Zhang S; Wang X; Gu Z; Wang L
Cancer Invest; 2016 Sep; 34(8):401-7. PubMed ID: 27559851
[TBL] [Abstract][Full Text] [Related]
12. TAT-IL-24-KDEL-induced apoptosis is inhibited by survivin but restored by the small molecular survivin inhibitor, YM155, in cancer cells.
Zhang J; Xu R; Tao X; Dong Y; Lv X; Sun A; Wei D
Oncotarget; 2016 Jun; 7(24):37030-37042. PubMed ID: 27203744
[TBL] [Abstract][Full Text] [Related]
13. YM155 sensitizes TRAIL-induced apoptosis through cathepsin S-dependent down-regulation of Mcl-1 and NF-κB-mediated down-regulation of c-FLIP expression in human renal carcinoma Caki cells.
Woo SM; Min KJ; Seo BR; Kwon TK
Oncotarget; 2016 Sep; 7(38):61520-61532. PubMed ID: 27528031
[TBL] [Abstract][Full Text] [Related]
14. Commitment toward cell death by activation of autophagy with survivin inhibitor YM155 in two canine squamous cell carcinoma cell lines with high expression of survivin.
Miyamoto R; Tani H; Ikeda T; Saima H; Tamura K; Bonkobara M
Res Vet Sci; 2021 Mar; 135():412-415. PubMed ID: 33160684
[TBL] [Abstract][Full Text] [Related]
15. Survivin inhibitor YM155 induces mitochondrial dysfunction, autophagy, DNA damage and apoptosis in Bcl-xL silenced glioma cell lines.
Jane EP; Premkumar DR; Sutera PA; Cavaleri JM; Pollack IF
Mol Carcinog; 2017 Apr; 56(4):1251-1265. PubMed ID: 27805285
[TBL] [Abstract][Full Text] [Related]
16. YM155 sensitizes non-small cell lung cancer cells to EGFR-tyrosine kinase inhibitors through the mechanism of autophagy induction.
Dai CH; Shu Y; Chen P; Wu JN; Zhu LH; Yuan RX; Long WG; Zhu YM; Li J
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3786-3798. PubMed ID: 30315932
[TBL] [Abstract][Full Text] [Related]
17. YM155 Reverses Cabazitaxel Resistance in Castration-resistant Prostate Cancer by Reducing Survivin Expression.
Miyao T; Koike H; Sekine Y; Ohtsu A; Oka D; Suzuki K
Anticancer Res; 2020 Sep; 40(9):5091-5095. PubMed ID: 32878797
[TBL] [Abstract][Full Text] [Related]
18. Preclinical assesement of survivin and XIAP as prognostic biomarkers and therapeutic targets in gastroenteropancreatic neuroendocrine neoplasia.
Dizdar L; Oesterwind KA; Riemer JC; Werner TA; Mersch S; Möhlendick B; Schütte SC; Verde PE; Raba K; Topp SA; Stoecklein NH; Esposito I; Knoefel WT; Krieg A
Oncotarget; 2017 Jan; 8(5):8369-8382. PubMed ID: 28039474
[TBL] [Abstract][Full Text] [Related]
19. Andrographolide promotes vincristine-induced SK-NEP-1 tumor cell death via PI3K-AKT-p53 signaling pathway.
Zhang M; Xue E; Shao W
Drug Des Devel Ther; 2016; 10():3143-3152. PubMed ID: 27729773
[TBL] [Abstract][Full Text] [Related]
20. YM155 enhances the cytotoxic activity of etoposide against canine osteosarcoma cells.
Ong SM; Saeki K; Kok MK; Nakagawa T; Nishimura R
J Vet Med Sci; 2019 Aug; 81(8):1182-1190. PubMed ID: 31308291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
